Multi-Parametric Magnetic Resonance Imaging to Rule-In and Rule-Out Clinically Important Prostate Cancer in Men at Risk: A Cohort Study.
Rouse P, Shaw G, Ahmed HU, Freeman A, Allen C, Emberton M.
Urol Int. 2011 Jun 22. [Epub ahead of print]
PMID: 21701136 [PubMed - as supplied by publisher]
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
Marberger M, Freedland SJ, Andriole GL, Emberton M, Pettaway C, Montorsi F, Teloken C, Rittmaster RS, Somerville MC, Castro R.
BJU Int. 2011 Jun 23. doi: 10.1111/j.1464-410X.2011.10373.x. [Epub ahead of print]
PMID: 21699645 [PubMed - as supplied by publisher]
Characterizing clinically significant prostate cancer using template prostate mapping biopsy.
Ahmed HU, Hu Y, Carter T, Arumainayagam N, Lecornet E, Freeman A, Hawkes D, Barratt DC, Emberton M.
J Urol. 2011 Aug;186(2):458-64. Epub 2011 Jun 15.
PMID: 21679984 [PubMed - in process]
Modelling Prostate Motion for Data Fusion during Image-guided Interventions.
Hu Y, Carter T, Ahmed H, Emberton M, Allen C, Hawkes D, Barratt D.
IEEE Trans Med Imaging. 2011 May 31. [Epub ahead of print]
PMID: 21632296 [PubMed - as supplied by publisher]
Time to rethink PSA screening.
Singh PB, Ahmed HU, Simmons L, Freeman A, Emberton M.
Arch Intern Med. 2011 Mar 28;171(6):595; author reply 595-6
PMID: 21444857 [PubMed - indexed for MEDLINE]
Focal Therapy for Localized Prostate Cancer: A Phase I/II Trial.
Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M.
J Urol. 2011 Apr;185(4):1246-55. Epub 2011 Feb 22.
PMID: 21334018 [PubMed - in process]
Related citations
Light penetration in the human prostate: a whole prostate clinical study at
763 nm.
Moore CM, Mosse CA, Allen C, Payne H, Emberton M, Bown SG.
J Biomed Opt. 2011 Jan-Feb;16(1):015003.
PMID: 21280905 [PubMed - in process]
Related citations
Risk stratification for benign prostatic hyperplasia (BPH) treatment.
Emberton M, Fitzpatrick JM, Rees J.
BJU Int. 2011 Mar;107(6):876-80. doi: 10.1111/j.1464-410X.2010.10041.x. Epub
2011 Jan 25.
PMID: 21265993 [PubMed - in process]
Related citations
MR to ultrasound registration for image-guided prostate interventions.
Hu Y, Ahmed HU, Taylor Z, Allen C, Emberton M, Hawkes D, Barratt D.
Med Image Anal. 2010 Dec 13. [Epub ahead of print]
PMID: 21216180 [PubMed - as supplied by publisher] Related citations
Surgical management after active surveillance for low-risk prostate cancer:
pathological outcomes compared with men undergoing immediate treatment.
Simmons L, Ahmed HU, Moore C, Emberton M.
BJU Int. 2011 Jan;107(2):338. doi: 10.1111/j.1464-410X.2010.10068_3.x. No abstract available.
PMID: 21208369 [PubMed - indexed for MEDLINE] Related citations
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.
Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M.
Eur Urol. 2011 Apr;59(4):477-94. Epub 2010 Dec 21.
PMID: 21195536 [PubMed - in process]
Related citations
Focal therapy for prostate cancer: a potential strategy to address the problem of overtreatment.
Lecornet E, Ahmed HU, Moore C, Emberton M.
Arch Esp Urol. 2010 Dec;63(10):845-52.
PMID: 21187566 [PubMed - in process]
Related citations
The influence of family history on prostate cancer risk: implications for clinical management.
Madersbacher S, Alcaraz A, Emberton M, Hammerer P, Ponholzer A, Schröder FH, Tubaro A.
BJU Int. 2011 Mar;107(5):716-721. doi: 10.1111/j.1464-410X.2010.10024.x.
Epub 2010 Dec 16.
PMID: 21166744 [PubMed - as supplied by publisher] Related citations
Ahmed HU, Emberton M. Is focal therapy the future for prostate cancer? Future Oncol. 2010 Feb;6(2):261-8. PMID: 20146585
Yap T, Emberton M. Behaviour modification and benign prostatic hyperplasia: replacement for medications. Curr Opin Urol. 2010 Jan;20(1):20-7. PMID: 19887949
Ahmed HU, Moore C, Lecornet E, Emberton M. Focal Therapy in Prostate Cancer: Determinants of Success and Failure.
J Endourol. 2010 Apr 9. [Epub ahead of print] PMID: 20380513
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group [Emberton M]. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 1;362(13):1192-202. PMID: 20357281
Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
BJU Int. 2010 Mar 25. [Epub ahead of print] PMID: 20346033
Armitage JN, van der Meulen JH; Royal College of Surgeons Co-morbidity Consensus Group [Emberton M]. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score.
Br J Surg. 2010 May;97(5):772-81. PMID: 20306528
Arumainayagam N, Kumaar S, Ahmed HU, Moore CM, Payne H, Freeman A, Allen C, Kirkham A, Emberton M. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy.
BJU Int. 2010 Mar 9. [Epub ahead of print] PMID: 20230392
Mark Emberton. Combination therapy – a strategy for BPH progression. Nature Reviews Urology 2010; 7 (May): 1-2
Hu Y, van den Boom R, Carter T, Taylor Z, Hawkes D, Ahmed HU, Emberton M, Allen C, Barratt D. A comparison of the accuracy of statistical models of prostate motion trained using data from biomechanical simulations. Prog Biophys Mol Biol. 2010 Sep 22. [Epub ahead of print] PMID: 20869389
Ahmed HU, Emberton M. Benchmarks for success in focal therapy of prostate cancer: cure or control? World J Urol. 2010 Oct;28(5):577-82. Epub 2010 Sep 10. PMID: 20830476
Lecornet E, Moore C, Ahmed HU, Emberton M. Focal therapy for prostate cancer: fact or fiction? Urol Oncol. 2010 Sep-Oct;28(5):550-6. PMID: 20816615
Singh PB, Ahmed HU, Emberton M. Active surveillance: is there a need for better risk stratification at the outset?
J Clin Oncol. 2010 Oct 1;28(28):e513. Epub 2010 Aug 9. No abstract available.
PMID: 20697073
Emberton M. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction.
Int J Clin Pract. 2010 Sep;64(10):1425-35. Epub 2010 Jun 22.
PMID: 20579137
Cathcart PJ, van der Meulen J, Emberton M, Kelly J. Volume-mortality for cystectomy. Centralisation of cancer services vindicated. BMJ. 2010 Jun 22;340:c3336. doi: 10.1136/bmj.c3336. PMID: 20570878
Dickinson L, Ahmed HU, Moore C, Freeman A, Kirkham A, Allen C, Emberton M. The effects of the time period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer. BJU Int. 2010 Jul;106(1):131-2; author reply 132. PMID: 20553478
Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.
BJU Int. 2010 Jun 14. [Epub ahead of print]
PMID: 20553262
de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, Frauscher F, Greene D, Harisinghani M, Haustermans K, Heidenreich A, Kovacs G, Mason M, Montironi R, Mouraviev V, de Reijke T, Taneja S, Thuroff S, Tombal B, Trachtenberg J, Wijkstra H, Polascik T. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010 May;24(5):775-80.PMID: 20477543
Arumainayagam N, Moore CM, Ahmed HU, Emberton M.
Photodynamic therapy for focal ablation of the prostate.
World J Urol. 2010 Oct;28(5):571-6. Epub 2010 May 9.
PMID: 20454966
Lecornet E, Ahmed HU, Moore CM, Emberton M.
Conceptual basis for focal therapy in prostate cancer.
J Endourol. 2010 May;24(5):811-8. PMID: 20443699
Hu Y, van den Boom R, Carter T, Taylor Z, Hawkes D, Ahmed HU, Emberton M, Allen C, Barratt D. A comparison of the accuracy of statistical models of prostate motion trained using data from biomechanical simulations. Prog Biophys Mol Biol. 2010 Sep 30. [Epub ahead of print] PMID: 20869389
Ahmed HU, Emberton M. Benchmarks for success in focal therapy of prostate cancer: cure or control? World J Urol. 2010 Oct;28(5):577-82. Epub 2010 Sep 10.
PMID: 20830476
Lecornet E, Moore C, Ahmed HU, Emberton M. Focal therapy for prostate cancer: fact or fiction? Urol Oncol. 2010 Sep-Oct;28(5):550-6. PMID: 20816615
Iremashvili VV, Chepurov AK, Emberton M, Vladimirov VG, Zarinskaia SA, Kobaladze KM. Significance of the number of biopsy specimens from the prostate gland for adequate clinical appraisal of neoplasia. Vopr Onkol. 2010;56(4):482-6. Russian. No abstract available. PMID: 20968031
20 peer reviewed articles published per year.
Professor Emberton has been invited as a Visiting Professor to The Mayo Clinic, UCLA, USA - 2010, Jikkei University, Tokyo, Japan - November 2010, Cornell University, New York, USA - January 2011 and The Memorial Sloan Kettering Cancer Center, New York, USA - January 2011. He also gives approximately 20 invited lectures per year in the UK and abroad.